Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

UBM Americas launches Cannabis Science and Technology as part of Life Sciences portfolio

Posted on: 06 Mar 18

ISELIN, N.J., March 06, 2018 (GLOBE NEWSWIRE) -- UBM Americas’ Life Sciences Group today announced the launch of Cannabis Science and Technology, a professional journal and website produced in alliance with the Cannabis Science Conference. This new resource focuses on educating the legal cannabis industry about the science and technology of analytical testing and quality control, including:   

  • Sample preparation techniques for analytical testing
  • Development of analytical methods for potency testing
  • Identifying contaminants such as pesticides, residual solvents, heavy metals, and mycotoxins
  • Quality control for cannabis, extraction, and processing
  • Laboratory best practices, laboratory certification
  • Testing standardization
  • Regulations related to quality control
  • Analytical methods for characterization of cannabinoids and terpenes

“The recent acceleration in the acceptance of cannabis as a valuable medical treatment places the industry at a critical juncture,” said Michael Tessalone, Vice President and Group Publisher of UBM Americas’ Life Science Group.  “With the launch of Cannabis Science and Technology, we are taking an important step to connect the scientific community we serve with the fast-growing cannabis industry.”

Cannabis Science and Technology joins the Pharmaceutical Science portfolio of UBM Americas’ Life Sciences group, with industry authorities such as LCGC global and Spectroscopy.  The journal will be published 4 times a year under the guidance of Stephanie Shaffer, Publisher, and Meg L’Heureux, Editor-in-Chief, to a circulation of 20,000, both digitally and in print, with continuous updates about new information and emerging research on its site.

To learn more, visit

About UBM Americas’ Life Sciences Group 
UBM Life Sciences is a US-based event, information, and marketing services business serving professional communities in human healthcare, veterinary medicine, and the pharmaceutical industry with an unmatched portfolio of in-person, print, and digital products. The business includes 4 trade shows, over 100 conferences, 30 publications, and over 100 digital products and websites. Reaching over 3.2 million life sciences professionals, UBM Life Sciences enables the professional communities it serves to learn, connect, and conduct business. UBM Life Sciences is a business unit of UBM Americas, a division of UBM plc.

About UBM plc
UBM plc is the largest pure-play B2B Events organiser in the world. In an increasingly digital world, the value of connecting on a meaningful, human level has never been more important. At UBM, our deep knowledge and passion for the industry sectors we serve allow us to create valuable experiences where people can succeed. At our events people build relationships, close deals and grow their businesses.

Our 3,750+ people, based in more than 20 countries, serve more than 50 different industry sectors – from fashion to pharmaceutical ingredients. These global networks, skilled, passionate people and market-leading events provide exciting opportunities for business people to achieve their ambitions.

For more information, go to; for UBM corporate news, follow us on Twitter at @UBM.

Media Contacts:

UBM Americas – Life Sciences Group
Amy Erdman                                                     


Last updated on: 07/03/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.